Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Parnell Pharmaceuticals Holdings’s financial performance into perspective.

 

Press Releases

Events & Presentations

Nov 2, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018

Aug 3, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018

Jul 31, 2018
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management

May 30, 2017 at 4:00 PM CT
Parnell Pharmaceuticals Holdings Ltd Annual General Meeting

May 24, 2017 at 5:00 PM ET
Parnell Pharmaceuticals Holding Ltd Business Update
Investors and analysts may access the conference call by dialing (877) 244-6184 (U.S./Canada) or (920) 663-6271 (International) and using the conference ID# 27440696

View all press releases >>

View all events & presentations >>

 
To
Top